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Angiogenic markers are elevated in women with
acute fatty liver of pregnancy
Acute fatty liver of pregnancy (AFLP) is a life-threatening,
pregnancy-specific condition with an estimated global
incidence of 1 in 7000 to 15 000 pregnancies1. Despite
several clinical characteristics unique to the disorder, dis-
tinguishing AFLP from other liver diseases of pregnancy,
such as hemolysis, elevated liver enzymes and low platelet
count (HELLP) syndrome or pre-eclampsia (PE), may be
challenging. Recent studies established an imbalance in
angiogenic factors, characterized by elevated levels of sol-
uble fms-like tyrosine kinase-1 (sFlt-1) and low placental
growth factor (PlGF) levels, as a key pathogenic mech-
anism underlying PE and HELLP syndrome2. However,
the role of these factors in the pathophysiology of AFLP
remains unknown. In this study, we measured serum levels
of sFlt-1 and PlGF in women with AFLP, and compared
them to those in women with suspected PE, confirmed PE
or HELLP syndrome.
We conducted a secondary analysis of a prospective
multicenter cohort study, in which women with AFLP,
suspected or confirmed PE or HELLP syndrome were
enrolled at three Dutch hospitals, originally aimed at eval-
uating the diagnostic value of sFlt-1, PlGF and sFlt-1/PlGF
ratio. Serum samples were collected and stored at −80◦C
upon study entry, and were measured at the end of
the study. We aimed to compare three gestational-age
matched women with suspected PE, confirmed PE or
HELLP syndrome, for each woman with AFLP.
Overall, 53 singleton and 25 twin pregnancies were
included. A total of 11 women diagnosed with AFLP
were evaluated, of whom six had singleton pregnancy
and five had twin pregnancy. In women diagnosed
with AFLP, median gestational age at study entry
was 36 (range, 34–38) weeks in those with singleton
pregnancy and 33 (range, 30–34) weeks in those with
twin pregnancy. In singleton pregnancies with HELLP
syndrome, gestational age was lower than in those
with suspected PE, confirmed PE or AFLP (Tables S1
and S2). In singleton pregnancies, women with AFLP
displayed higher serum sFlt-1 levels than women with
suspected or confirmed PE (Figure 1). When comparing
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Figure 1 Box-and-whiskers plots showing circulating levels of
soluble fms-like tyrosine kinase-1 (sFlt-1) (a), placental growth
factor (PlGF) (b) and sFlt-1/PlGF ratio (c) in 53 singleton pregnan-
cies, according to clinical diagnosis. P<0.05 for comparison with:
*suspected pre-eclampsia (PE) group; †confirmed PE group; and
‡hemolysis, elevated liver enzymes and low platelet count (HELLP)
syndrome group. Boxes show median and interquartile range, and
whiskers are range. AFLP, acute fatty liver of pregnancy.
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Figure 2 Box-and-whiskers plots showing circulating levels of
soluble fms-like tyrosine kinase-1 (sFlt-1) (a), placental growth
factor (PlGF) (b) and sFlt-1/PlGF ratio (c) in 25 twin pregnancies,
according to clinical diagnosis. There were no significant
differences between groups. Boxes show median and interquartile
range, and whiskers are range.
PlGF levels in singleton pregnancies, women diagnosed
with HELLP syndrome displayed lower levels than women
with suspected PE, confirmed PE or AFLP, whereas the
sFlt-1/PlGF ratio was higher in both women with HELLP
syndrome and AFLP, when compared with the suspected
PE group, and higher in women with HELLP syndrome
when compared to the confirmed PE group. No differences
in sFlt-1 or PlGF levels or sFlt-1/PlGF ratio were observed
between twin pregnancies with suspected PE, confirmed
PE and AFLP (Figure 2). Our previous observation that
non-pre-eclamptic twin pregnancies exhibit higher sFlt-1
levels than non-pre-eclamptic singleton pregnancies due
to increased placental mass3, may provide an explanation
for this lack of difference.
Our results, together with the observations of Suzuki
et al.4, who reported an elevated sFlt-1/PlGF ratio in a
woman with AFLP in comparison to 14 women with
HELLP syndrome, imply a potential role for sFlt-1 in
the pathophysiology of AFLP. One could suggest that
the mechanisms underlying PE, HELLP syndrome and
AFLP are all a consequence of an antiangiogenic state,
which may explain why these disorders coexist in 20%
of cases1. This is indirectly supported by preclinical
studies in which tyrosine-kinase inhibitors were used as an
antiangiogenetic treatment, resulting in impaired hepatic
mitochondrial oxidation5. Nonetheless, we encourage
future studies to investigate the role of angiogenic factors,
particularly sFlt-1, in the pathogenesis of AFLP.
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SUPPORTING INFORMATION ON THE
INTERNET
The following supporting information may be
found in the online version of this article:
Table S1 Patient characteristics and outcome in
53 singleton pregnancies, according to clinical
diagnosis
Table S2 Patient characteristics and pregnancy
in 25 twin pregnancies, according to clinical
diagnosis
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